Publications by authors named "S Veszelka"

Article Synopsis
  • Human stem cell-derived blood-brain barrier (BBB) models are crucial for understanding brain diseases and drug development, but creating endothelial cells with proper BBB characteristics is a challenge.
  • Researchers developed a small-molecule cocktail called cARLA that activates specific signaling pathways to enhance BBB properties in endothelial cells, specifically through the tight junction protein claudin-5.
  • cARLA not only helps human BBB models better mimic in vivo brain endothelial characteristics but also improves their ability to predict how well drugs and nanoparticles can penetrate the brain, making it a promising tool for research and drug development.
View Article and Find Full Text PDF

A great progress has been made in the development and use of lab-on-a-chip devices to model and study the blood-brain barrier (BBB) in the last decade. We present the main types of BBB-on-chip models and their use for the investigation of BBB physiology, drug and nanoparticle transport, toxicology and pathology. The selection of the appropriate cell types to be integrated into BBB-on-chip devices is discussed, as this greatly impacts the physiological relevance and translatability of findings.

View Article and Find Full Text PDF

Nanoparticles (NPs) are the focus of research efforts that aim to develop successful drug delivery systems for the brain. Polypeptide nanocarriers are versatile platforms and combine high functionality with good biocompatibility and biodegradability. The key to the efficient brain delivery of NPs is the specific targeting of cerebral endothelial cells that form the blood-brain barrier (BBB).

View Article and Find Full Text PDF

In our present series of experiments, we investigated the nasal applicability of the previously developed Soluplus® - meloxicam polymeric micelle formulation. Utilizing the nasal drug investigations, moderately high mucoadhesion was experienced in nasal conditions which alongside the appropriate physicochemical properties in liquid state, contributed to rapid drug absorption through human RPMI 2650 cell line. Ex vivo studies also confirmed that higher nasal mucosal permeation could be expected with the polymeric micelle nanoformulation compared to a regular MEL suspension.

View Article and Find Full Text PDF

The application of 2-hydroxypropyl-beta-cyclodextrin (HPBCD) in the treatment of the rare cholesterol and lipid storage disorder Niemann-Pick disease type C opened new perspectives in the development of an efficient therapy. Even if the systemic administration of HPBCD was found to be effective, its low permeability across the blood-brain barrier (BBB) limited the positive neurological effects. Nevertheless, the cellular interactions of HPBCD with brain capillary endothelial cells have not been investigated in detail.

View Article and Find Full Text PDF